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A B S T R A C T
Purpose: To describe the clinical and electrophysiological features of an unusual retinopathy in a patient with a
novel genotype of CNGB1, mutations in which are implicated in autosomal recessive retinitis pigmentosa (rod-
cone dystrophy).
Observations: A 61-year old asymptomatic woman was referred to the inherited retinal disorders clinic because
of peripheral retinal pigmentary changes. She had normal visual acuity and color vision. Clinical examination
and detailed imaging of the macula were normal, but there was atrophy of the outer retina in the periphery with
sparse intra-retinal pigmentation. Electroretinography (ERG) revealed undetectable rod responses, with normal
cone-mediated responses. The pattern ERG was normal. Genetic analysis identiﬁed two previously unreported
variants in CNGB1: (c.2258T > A, p.[Leu753*] and c.807G > C, p.[Gln269His]), shown to be in trans.
Conclusions and importance: This report describes a functionally cone-isolated retina in an adult, apparently
hemizygous for a novel missense mutation in CNGB1, a novel phenotype for this gene. The p.[Gln269His] allele
is the ﬁrst missense change, within the glutamic acid-rich protein (GARP) domain of CNGB1, to be associated
with retinal disease in humans.
1. Introduction
Light absorption at the photoreceptor outer segment activates the
phototransduction cascade, which results in hydrolysis of the 3′-5′-
cyclic GMP (cGMP) by the activated phosphodiesterase. This leads to
closure of the cyclic nucleotide-gated (CNG) channels in the photo-
receptor outer segment and hyperpolarization of the photoreceptors.1
The CNG channels conduct the photoreceptor ion currents and are
modulated by cGMP.1 The rod CNG channels are heterotetramers
composed of one β1-subunit and three α1-subunits.2 The α1-subunits
control the gating of the CNG channel, and the β1-subunits modulate
the kinetics of the gating in response to cGMP.2 CNGB1 encodes the β1-
subunits as well as two soluble glutamic-acid rich proteins (GARPs).3
The function of the GARP domains has not been fully elucidated, but in
vitro studies implicated these proteins in the modulation of the rod CNG
channels.3,4
Biallelic mutations in CNGB1, associated with autosomal recessive
rod-cone dystrophy (retinitis pigmentosa, RP, MIM 613767), are com-
monly presumed ‘null’ (nonsense, frameshifting, splice-site mutations)
but missense mutations have also been reported.5,6 Expression of
CNGB1 in the retina is restricted to the rod photoreceptors, and the
observed cone dysfunction evident in cases with RP is likely consequent
upon outer retinal degeneration.7 A recent report of ten patients with
autosomal recessive retinitis pigmentosa due to CNGB1 mutations
showed that despite childhood-onset nyctalopia, peripheral visual ﬁeld
constriction could occur no later than the third decade of life, with all
patients showing subnormal photopic ERG responses in the absence of
rod responses.8
This report describes a case with a novel phenotype associated with
biallelic mutations in CNGB1.
2. Case report
A 61-year-old woman, of South Asian ancestry, was referred to the
inherited retinal disorders clinic with bilateral peripheral retinal pig-
mentary changes detected on routine diabetic retinopathy screening.
The patient had controlled non-insulin dependent diabetes mellitus but
was otherwise well. There was no family history of consanguinity,
nyctalopia, or poor vision; and both parents had normal vision into
their seventh decade of life (Fig. 1).
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The patient reported no night blindness initially but on direct
questioning, mentioned slightly prolonged adaptation to dim lighting
conditions. Visual acuity was 20/20 in the right eye, 20/30 left, with
normal color vision tested using the Hardy, Rand, and Rittler plates.
Although formal perimetry was not performed, as the patient did not
wish to undergo further testing, the visual ﬁelds to confrontation were
normal. There were mild cataracts in both eyes. Fundus examination
showed normal retinal appearance in the posterior pole, with
peripheral retinal atrophic changes and sparse intra-retinal pigment in
both eyes. There were no signs of diabetic retinopathy (Fig. 2). Spectral-
domain optical coherence tomography (OCT) of the central macula was
normal bilaterally. Wide-ﬁeld fundus autoﬂuorescence (FAF) showed
peripheral hyperautoﬂuorescence in the nasal and inferior quadrants.
Full ﬁeld and pattern electroretinography (ERG; PERG) were per-
formed, using extended protocols that incorporated those of the
International Society for Clinical Electrophysiology of Vision.9–11 The
results are shown in Fig. 3. The PERG P50 and N95 components were
normal and revealed no evidence of macular or retinal ganglion cell
dysfunction. The dark-adapted (DA) dim ﬂash rod (DA 0.01) ERG was
undetectable bilaterally. The DA red ﬂash ERG showed preservation of
the x-wave, derived from DA cones, but the rod-mediated b-wave was
undetectable bilaterally. The DA 3.0 ERG a-wave was reduced, and the
waveform had a low b:a ratio, with a b-wave of similar peak time and
shape to the DA red ﬂash ERG x-wave. The DA 10.0 (strong ﬂash) ERG
a-wave was subnormal and the b-wave was of lower amplitude than the
a-wave. Light-adapted (LA 3.0) 30 Hz ﬂicker and single ﬂash cone (LA
3.0) ERG were normal for age. The ERG ﬁndings are consistent with a
severe and selective loss of rod photoreceptor function, with DA 3.0 and
DA 10.0 ERGs (mixed rod and cone system responses) likely re-
presenting contributions from the dark-adapted cone system only (the
photopic hill phenomenon). Vitamin A (retinol) serum level was sub-
sequently measured and was normal (2.09 μmol/l; normal range:
0.66–4.87μmol/l).12
After obtaining informed consent, a blood sample was collected for
genetic testing and the DNA was extracted. Because of the mild per-
ipheral retinal changes, initial screening for mutations in RHO, by
Sanger sequencing of all coding exons and intron-exon boundaries,
identiﬁed no pathogenic variants. Subsequently, whole exome se-
quencing (WES) and deletion and duplication analysis were undertaken
as described previously.13 Filtering of the variants, including deletions
and duplications, was performed as follows: variants that met the fol-
lowing criteria were identiﬁed, using the Ingenuity Variant Analysis
Fig. 1. Pedigree GC20043: both parents (I:1, I:2) were asymptomatic in their
seventies. The proband II:3 has two asymptomatic older siblings, one of whom
(female, aged 71 years) is heterozygous for the nonsense mutation M2: p.
[Leu753*] but not the missense change M1: p.[Gln269His]; and three asymp-
tomatic children one of whom is heterozygous for the nonsense mutation M2,
but did not harbour the missense change M1; indicating that the two mutations
are in trans in II:3 and segregate at least in two clinically discordant siblings, as
expected for a recessive disorder. W: wild type allele.
Fig. 2. Fundus imaging: (A) wide-ﬁeld retinal
images, showing the right and left fundi. The pos-
terior pole shows no abnormalities, but the mid-
peripheral retina shows mild pallor (arrow) sug-
gesting outer retinal degeneration. The left fundus
shows sparse intra-retinal pigment (inset); an in-
cidental vitreous opacity is marked with the asterisk
(*). (B) fundus autoﬂuorescence (AF) showing bi-
laterally normal signal in the posterior pole, how-
ever, the AF signal intensity is increased in the mid-
peripheral retina (arrow) with an edge that almost
co-localizes with that seen on the pseudo-color
image. The AF signal is reduced in the far-peripheral
retina. (C) optical coherence tomography of the
right and left maculae, showing normal structure.
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tool (QIAGEN Bioinformatics, USA), and prioritized: i) variants in genes
that have been associated with retinal disease (https://sph.uth.edu/
retnet/, accessed 12 January 2018); ii) labelled as high or moderate
impact (splice-site, mutations that cause loss of the start codon, non-
sense, non-synonymous and frameshifting mutations); iii) those with an
allele frequency in the gnomAD dataset (http://gnomad.broadinstitute.
org/) of less than 0.001. Additionally, the WES data including a sepa-
rate analysis for deletions and insertions were manually interrogated
for known mutations in genes associated with retinal disease, with al-
lele frequencies greater than 0.001. The variants that met these criteria
are given in Table S1. The CNGB1 gene harboured two rare variants
that survived ﬁltering, in keeping with the expected inheritance for the
gene: c.2258T > A, p.[Leu753*], and c.807G > C, p.[Gln269His]
(transcript NM_001297.4). In silico prediction tools showed the p.
[Gln269His] to be deleterious with a SIFT score of 0, and probably
damaging with a PolyPhen-2 score of 0.99. Multiple alignments of the
amino acid sequences of CNGB1 showed the glutamine residue at po-
sition 269 to be conserved in diverse vertebrate species (Fig. S1). Nei-
ther variants had been reported in the literature, nor seen in 246,080
(p.[Leu753*]) and 246,190 (p.[Gln269His]) alleles in the gnomAD
database. The two alleles are most likely to be in trans and segregated
with retinal dysfunction. This was conﬁrmed by DNA sequencing of her
oﬀspring who harbored only the p.[Leu753*] variant (Fig. 1). The pa-
tient's sibling (age 71 years) had a normal clinical examination and ERG
and was shown to harbour only the p.[Leu753*] variant. No other fa-
mily members were available for genetic analysis.
3. Discussion
This report describes an unusual retinal functional phenotype
characterised by full-ﬁeld ERG evidence of severe and selective loss of
rod photoreceptor function, associated with novel missense and non-
sense mutations in CNGB1. There may be localized areas of atrophy and
intra-retinal pigment in the periphery, but the fundus abnormalities are
mild compared with the severity of rod dysfunction and are too focal to
aﬀect either the cone-mediated full-ﬁeld ERGs or macular function. The
ERG features are consistent with a functionally cone-isolated retina (see
Fig. 3) and resemble those in fundus albipunctatus due to mutations in
RDH5 and Oguchi disease caused by mutations in either SAG or GRK1.
Both these forms of congenital stationary night blindness (CSNB) are
usually characterised by distinctive fundus abnormalities and recovery
of rod-mediated ERGs after extended dark adaptation,14 but no such
genetic variants were present on WES. A normal retinal appearance and
irreversible absence of rod function with preservation of cone function
(“Riggs-type CSNB”), may also be caused by dominant alleles of
GNAT1, PDE6B, RHO, and recessive alleles of SLC24A1.14
To date, 30 likely disease-causing CNGB1 mutations have been re-
ported in patients with RP (Fig. 4). Only 7 of these were missense
changes, mainly clustering within the trans-membrane domains or the
cyclic nucleotide binding domain6. In this case, the p.[Leu753*] variant
is likely to be subjected to nonsense-mediated decay, but if translated
the resulting protein would lack the carboxyl 468 amino acid residues,
and be still non-functional. It is probable then, that the missense mu-
tation, p.Gln269His, confers the unusual retinal pathology. This variant
exchanges a glutamine residue for histidine within a conserved recur-
ring motif, a Pro-Gln-Pro triplet, in the GARP domain of the protein
(Fig. 4). Interestingly, no disease-causing missense mutations within the
GARP domain have been previously reported to our knowledge.15 The
precise function of this domain has not been established.3,4,15 However,
conservation of this domain in vertebrates suggests that it has an im-
portant function. It is reasonable to speculate that the missense muta-
tion p.Gln269His, allows processing and assembly of the rod CNG
channel but renders it insensitive to cGMP modulation. This might still
allow ﬂow of Ca2+ ions to an extent that achieves a non-toxic in-
tracellular concentration, but somehow abrogate the timely closure to
light abolishing the rod response. Further biochemical analysis of this
mutant and its function in response to changes in cGMP concentrations
would be required to understand the precise pathophysiology.
4. Conclusion
This report describes an unusual phenotype of a functionally cone-
isolated retina associated with a novel missense mutation, in the GARP
domain of CNGB1 in trans with a predicted loss-of-function variant. The
Fig. 3. Full ﬁeld electroretinogram (ERG) for the right (RE) and left eye (LE) of the proband, and a 72- year-old normal control (N). The dark-adapted, rod-speciﬁc
ERG response (DA 0.01) is undetectable bilaterally; using a red ﬂash, under dark adaptation (0.3 cd.s m−2), shows a clear response from the dark-adapted cones (x-
wave, peak time 47ms (RE) and 46ms (LE)) but no rod component. The dark-adapted response to the 3.0 cd.s m−2 shows subnormal a-wave and b-wave with a b-
wave peak time of 49ms (RE), and 46ms (LE). The similarity between the peak times of the x-wave and the b-wave of the DA 3.0 suggests that both responses are
driven by the dark-adapted cones. The bright ﬂash dark-adapted ERG (DA 10.0) shows a delayed and subnormal a-wave, with reduced b:a ratio in keeping with a
dark-adapted cone system origin. Photopic ﬂicker (LA 30 Hz) and single ﬂash ERGs (LA 3.0) show normal amplitudes and peak times. The pattern ERG (PERG) was
within the normal range for age.
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phenotype is rare and indistinguishable from documented cases of
“Riggs-type CSNB”, with relatively mild peripheral retinal changes
suggesting possible slow degeneration. The case highlights the im-
portance of an intact GARP domain of the CNGβ1 subunit in the
function of the rod photoreceptors.
Patient consent
Written consent to publish this case has been obtained from the
patient as part of the ongoing genotype-phenotype correlation study
approved by the local ethics committees.
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Fig. 4. Schematic representation of the CNGB1 protein (A) from the canonical transcript ENST00000251102 (B) modiﬁed from: http://www.ensembl.org/Homo_
sapiens/Transcript/Summary?db=core;g=ENSG00000070729;r=16:57882340-57971116;t=ENST00000251102). The CNGB1 gene product has a glutamic-acid
rich protein (GARP) domain, a calmodulin-binding domain (CaM), and six trans-membrane domains (S1-S6) including the pore-forming domain (P), and a cyclic
nucleotide binding domain (CNBD).16 The previously reported disease-causing mutations are shown on A; top: missense changes including the variant p.[Gln269His]
(red); bottom: nonsense and frameshifting mutations including the p.[Leu753*] (red) mutation. (B): the previously reported splice-site mutations are aligned with the
CNGB1 exons. . (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the Web version of this article.)
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